Home

RICHARD U DE SCHUTTER

CIK 1083205 · last filed 2024-04-02

RICHARD U DE SCHUTTER is a corporate insider who has filed 90 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider was granted $26.9K of BLCO on Apr 2, 2024. Across all open-market trades the lifetime net is −$7.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $17.6M across reported positions. 44 SEC filings were submitted jointly with Bausch Health Companies Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$17.60M

Companies

5

Total Filings

90

Lifetime Open-Market Net

-$7.25M

Filer Profile

Reported Address
C/O BLCO
400 SOMERSET CORPORATE BLVD.
BRIDGEWATER, NJ 08807
Related Filers
Bausch Health Companies Inc. — 44 joint filings, latest 2023-04-04
INCYTE CORP — 22 joint filings, latest 2015-03-09
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BLCO Director 32,952 $18.04 $594.5K $0 7 2024-04-02
BHC Director 387,207 $6.56 $2.54M $3.43M 26 2023-04-04
INCY Director 92,290 $126.75 $11.70M -$10.78M 15 2015-03-09
Durata Therapeutics, Inc. (DRTX) Delisted Director — — — $0 1 2013-05-20
ECL Director 9,900 $279.28 $2.77M $104.5K 19 2010-04-20

Recent Filings

90 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-04-02 BLCO Grant (A) +1,553 $26.9K EDGAR
2024-01-03 BLCO Grant (A) +1,575 $26.9K EDGAR
2023-10-03 BLCO Grant (A) +1,585 $26.9K EDGAR
2023-07-05 BLCO Grant (A) +1,339 $26.9K EDGAR
2023-05-05 BLCO Grant (A) +12,857 $0 EDGAR
2023-04-04 BLCO Grant (A) +1,543 $26.9K EDGAR
2023-04-04 BHC Grant (A) +3,642 $29.5K EDGAR
2023-01-03 BHC Grant (A) +5,186 $32.6K EDGAR
2022-10-03 BHC Grant (A) +4,989 $34.4K EDGAR
2022-07-05 BHC Grant (A) +4,111 $34.4K EDGAR
Showing 1–10 of 90
Page 1 of 9
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.